Cadila Pharmaceuticals launches Vasograin Plus for treatment of migraines

Vasograin Plus represents a major advancement in the treatment of migraine

Cadila Pharmaceuticals launches Bilacad Dex Syrup

A triple-action Formula for comprehensive respiratory relief

Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,

Cadila launches Cadilose for constipation and hepatic encephalopathy

Cadila Pharmaceuticals opens advanced pharmaceutical warehouse

Indian Red Cross Society and Cadila to launch training of 50,000 students for CPR and First Aid

The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state

CII recognized Cadila among Top 50 Innovative Companies in India

Cadila launches Rs. 200 crore API facility in Dahej

Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore

Cadila plans an injectable manufacturing facility in collaboration with Russia

The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries

Cadila Pharmaceuticals appoints Ashraf Allam as Global COO

Allam was serving recently as the CEO at Public Investment Fund